Covered recipient · General Payments record
SAUMYAJIT DATTA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$7,723.00
- Reported across 185 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $426.03 | 14 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $178.57 | 4 |
| Lilly USA, LLC | $90.38 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.52 | 1 |
| Exact Sciences Corporation | $22.82 | 1 |
| PFIZER INC. | $21.03 | 1 |
| Organon LLC | $18.28 | 1 |
| Novo Nordisk AS | $17.25 | 1 |
| GlaxoSmithKline, LLC. | $17.09 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $125.00 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020117529 | CMS |
| Amgen Inc. | $24.59 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020117521 | CMS |
| Amgen Inc. | $20.09 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020674549 | CMS |
| Amgen Inc. | $8.89 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020117525 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.09 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000088151 | CMS |
| Exact Sciences Corporation | $22.82 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026575493 | CMS |
| GlaxoSmithKline, LLC. | $17.09 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002303657 | CMS |
| Lilly USA, LLC | $33.02 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032184141 | CMS |
| Lilly USA, LLC | $25.78 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032208981 | CMS |
| Lilly USA, LLC | $31.58 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032387797 | CMS |
| Novo Nordisk Inc | $17.25 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001284593 | CMS |
| Organon LLC | $18.28 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046926611 | CMS |
| PFIZER INC. | $21.03 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049594153 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.52 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055375075 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.